ToxoTech AB
559234-1456ActiveDeveloping precision-engineered next-generation botulinum neurotoxin therapeutics for neurological disorders.
Overview
- 1
- Employees
- 738K SEK
- Revenue
- 2019
- Founded
Key Decision Makers
Jonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Ellen Walse
Scientist
+1 more contacts in Funnelfeedr
Description
ToxoTech is a Stockholm-based biopharmaceutical company founded in 2020 as a spin-out from Stockholm University. The organization specializes in advancing the science behind next-generation botulinum neurotoxin (BoNT) therapeutics. Their core technology focuses on engineering improved toxin-receptor...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559234145601
Decision Makers
5 contacts in FunnelfeedrJonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Other Contacts
Ellen Walse
Scientist
Sara Persson Košenina
Principal Scientist
Similar Companies
20 similar companies in Funnelfeedr
MERZ THERAPEUTICS NORDICS AB
Nordic therapeutics company specializing in neurological movement disorder treatments.
MitoTech AB
0 employeesDeveloping novel small molecules to restore mitochondrial function in diseases.
AB MAvatar
22 employeesAI platform transforming biomedical data into personalized medicine insights.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Tablestat Technologies Nordic AB
1–4 employeesAI-powered platform for deal sourcing, buyer mapping, and valuation.
Browse More
ToxoTech AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo